These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26051860)

  • 1. [Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study].
    Leroyer C; Mahé I; Daurès JP; Quéré I; Aubin C; Compagnon A; Doussaint J; Schück S; Pouchain D
    J Mal Vasc; 2015 Jul; 40(4):248-58. PubMed ID: 26051860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of venous thromboembolic events by fondaparinux 2.5 mg in general practice. ArchiMed Ville].
    Mahé I; Daurès JP; Pouchain D; Quéré I; Aubin C; Doussaint J; Schück S; Leroyer C
    J Mal Vasc; 2015 Dec; 40(6):365-75. PubMed ID: 26205797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The PROMET study: Prophylaxis for venous thromboembolic disease in at-risk patients hospitalized in Algeria].
    Guermaz R; Belhamidi S; Amarni A
    J Mal Vasc; 2015 Jul; 40(4):240-7. PubMed ID: 26051861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
    Cohen AT; Davidson BL; Gallus AS; Lassen MR; Prins MH; Tomkowski W; Turpie AG; Egberts JF; Lensing AW;
    BMJ; 2006 Feb; 332(7537):325-9. PubMed ID: 16439370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
    Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
    J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta.
    Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR
    Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Geerts WH; Bergqvist D; Pineo GF; Heit JA; Samama CM; Lassen MR; Colwell CW
    Chest; 2008 Jun; 133(6 Suppl):381S-453S. PubMed ID: 18574271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study.
    Ageno W; Riva N; Noris P; Di Nisio M; La Regina M; Arioli D; Ria L; Monzani V; Cuppini S; Lupia E; Giorgi Pierfranceschi M; Dentali F;
    J Thromb Haemost; 2012 Nov; 10(11):2291-7. PubMed ID: 22925036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FondaKIDS II: long-term follow-up data of children receiving fondaparinux for treatment of venous thromboembolic events.
    Ko RH; Michieli C; Lira JL; Young G
    Thromb Res; 2014 Sep; 134(3):643-7. PubMed ID: 25087891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
    Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
    J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.